Could psychedelics open new doors for science and business? : psychedelic medicines and therapies are becoming more mainstream and may offer innovative solutions in an era of declining mental health and well-being /

Saved in:

Bibliographic Details
Author / Creator:	Meister, Alyson, author.
Edition:	[First edition].
Imprint:	[Cambridge, Massachusetts] : MIT Sloan Management Review, 2022.
Description:	1 online resource (5 pages)
Language:	English
Subject:	Hallucinogenic drugs -- Therapeutic use. Hallucinogenic drugs -- Therapeutic use
Format:	E-Resource Book
URL for this record:	http://pi.lib.uchicago.edu/1001/cat/bib/13707271

Hidden Bibliographic Details
Other authors / contributors:	Oppegaard, Kaja, author. Grotefeld, Eric, author. Bouquet, Cyril, author.
Notes:	"Reprint 64230."
Summary:	Psychedelic drugs have a history clouded by stigma, but a new wave of clinical research could change how they're perceived and used. Today, a psychedelic renaissance points to potential uses of such drugs in the fields of psychiatry, mental health, and well-being. Some companies have seized upon psychedelics' potential to treat psychological conditions and spur creativity and are making business investments that they hope will pay off in breakthroughs that improve people's lives.
Standard no.:	53863MIT64230

Similar Items